Peptide profile
Palmitoyl Tetrapeptide-7 (Rigin variant)
Palmitoylated tetrapeptide-7 for skin repair
Compare Palmitoyl Tetrapeptide-7 (Rigin variant) with other peptides →Summary
A tiny skin helper that fixes collagen and calms redness.
- Typical dose
- 2-5% concentration 1-2x daily
- Route
- Topical
- Cycle length
- Ongoing
- Evidence
- Limited human data
Mechanism
How it works
Palmitoyl tetrapeptide-7 works like a courier service — the palmitoyl tail delivers the anti-inflammatory and collagen-boosting message deep into skin.
Palmitoyl tetrapeptide-7 is a lipophilic analog of tetrapeptide-7 (Rigin) with enhanced penetration, mimicking SPARC's ECM-modulating activity.
Reported in research
Benefits
- Calms swelling and redness in your skin
- Helps your skin make more collagen, which keeps skin strong
- Makes skin firmer and more stretchy
- Repairs skin damaged by the sun or aging
Context, not a prescription
Dosing
- Typical range
- 2-5% concentration 1-2x daily (Topical)
- Cycle length
- Ongoing
Safety
Side effects & contraindications
Possible side effects
- Minimal; very well tolerated
- Mild irritation
Contraindications
- Known peptide sensitivity
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
Firmer skin, fewer fine lines, and less redness and swelling.
How it works
Palmitoyl tetrapeptide-7 works like a delivery driver. Its fatty tail carries the calming, collagen-boosting message deep into your skin.
It calms the signals that cause swelling. At the same time, it boosts helpers that repair the skin's support structure.
What to expect
You can see your skin improve in 4-6 weeks.
- Weeks 2-3: Less redness and irritation.
- Weeks 4-6: Skin feels firmer and smoother.
- Weeks 8-12: Wrinkles look smaller and sun damage fades.
Good to know
- Test a tiny spot on your skin first
Staying safe
- Almost none; very gentle on skin
Avoid if you have:
- People whose skin reacts badly to these tiny proteins
Mechanism of action
Palmitoyl tetrapeptide-7 is a lipophilic analog of tetrapeptide-7 (Rigin) with enhanced penetration, mimicking SPARC's ECM-modulating activity.
Reduces cytokine-induced inflammation while upregulating growth factors for extracellular matrix repair.
Pharmacodynamics
Visible improvement at 4-6 weeks.
Firmer skin, reduced fine lines, less redness and inflammation.
Timeline
- Weeks 2-3: Reduced redness and irritation.
- Weeks 4-6: Improved skin firmness and texture.
- Weeks 8-12: Reduced wrinkle depth and sun damage.
Comparisons
- Palmitoyl Tetrapeptide-7 — effectiveness High, safety Excellent, cost $$, Very Easy to use
- Rigin — effectiveness High, safety Excellent, cost $$, Very Easy to use
Adverse effects
Common:
- Minimal; very well tolerated
Rare:
- Mild irritation
Contraindications & risk mitigation
Contraindicated in:
- Known peptide sensitivity
- Patch test first
Qué hace
Piel más firme, menos líneas finas y menor enrojecimiento e hinchazón.
Cómo funciona
El tetrapeptido-7 palmitoilado funciona como un repartidor. Su cola grasa transporta el mensaje calmante y estimulante de colágeno profundamente en tu piel.
Calma las señales que causan hinchazón. Al mismo tiempo, potencia los factores que reparan la estructura de soporte de la piel.
Qué esperar
Puedes notar una mejora en tu piel en 4-6 semanas.
- Semanas 2-3: Menos enrojecimiento e irritación.
- Semanas 4-6: La piel se siente más firme y suave.
- Semanas 8-12: Las arrugas se ven más pequeñas y el daño solar disminuye.
Bueno saber
- Prueba en una pequeña zona de tu piel primero
Manteniéndose seguro
- Casi ninguno; muy suave con la piel
Evitar si tienes:
- Personas cuya piel reacciona mal a estas pequeñas proteínas
Mecanismo de acción
El tetrapeptido-7 palmitoilado es un análogo lipofílico del tetrapeptido-7 (Rigin) con una penetración mejorada, que imita la actividad moduladora de la matriz extracelular (MEC) de la proteína SPARC.
Reduce la inflamación inducida por citoquinas mientras regula al alza los factores de crecimiento para la reparación de la matriz extracelular.
Farmacodinamia
Mejora visible a las 4-6 semanas.
Piel más firme, reducción de líneas finas, menos enrojecimiento e inflamación.
Cronología
- Semanas 2-3: Reducción del enrojecimiento y la irritación.
- Semanas 4-6: Mejora de la firmeza y textura de la piel.
- Semanas 8-12: Reducción de la profundidad de las arrugas y el daño solar.
Comparaciones
- Palmitoyl Tetrapeptide-7 — efectividad Alta, seguridad Excelente, costo $$, Muy fácil de usar
- Rigin — efectividad Alta, seguridad Excelente, costo $$, Muy fácil de usar
Efectos adversos
Comunes:
- Mínimos; muy bien tolerado
Raros:
- Irritación leve
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Sensibilidad conocida a péptidos
- Realizar prueba de parche primero
Reference data
Specifications
- Route
- Topical
- Cycle length
- Ongoing
FAQ
Common questions
Is this the same as Matrixyl 3000?
Yes, Matrixyl 3000 is a combination of palmitoyl tetrapeptide-7 and palmitoyl oligopeptide.
Can it help with rosacea?
Yes, by reducing inflammatory cytokines, it can calm redness associated with rosacea.
What is the evidence level?
This compound is classified as Limited human data. Some human data exists but trials are small, short-term, or not yet replicated.
Research
Research & sources
Current evidence for Palmitoyl Tetrapeptide-7 (Rigin variant) is rated as Limited human data. Limited human data is available.
- 1. Palmitoyl tetrapeptide-7 study (2005) — DOI:10.1111/j.1468-2494.2005.00245.x
- 2. Palmitoyl tetrapeptide-7 study (2005)